Large-scale testing (Phase 3)Study completedNCT05048342
What this trial is testing
A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines
Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 71